A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions

Clinical trial NCT06879132 · COMPLETED

Trial details

NCT number: NCT06879132
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-11-05
Primary completion: 2024-12-07
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.